REBIF, REBIF REBIDOSE, Rebif

What is this medication? Rebif and the Rebif Rebidose autoinjector are brand names for a prescription medication known as interferon beta-1a. This medicine is specifically used to treat adults who have relapsing forms of multiple sclerosis, a condition where the immune system attacks the central nervous system. It is indicated for patients with clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease to help manage the course of the illness.

The medication works by modulating the body's immune response to reduce the inflammation that causes damage to nerve fibers. Its primary goals are to decrease the frequency of clinical exacerbations, which are commonly referred to as relapses or flare-ups, and to slow the accumulation of physical disability over time. By regulating certain immune functions, it helps limit the number of new brain lesions that are typically visible on imaging scans in patients with multiple sclerosis.